Cargando…
In Vitro Activity of Novel Topoisomerase Inhibitors against Francisella tularensis and Burkholderia pseudomallei
Antimicrobial resistance is a global issue, and the investigation of alternative therapies that are not traditional antibiotics are warranted. Novel bacterial type II topoisomerase inhibitors (NBTIs) have recently emerged as a novel class of antibiotics with reduced potential for cross-resistance to...
Autores principales: | Whelan, Adam O., Cooper, Ian, Ooi, Nicola, Orr, David, Blades, Kevin, Kirkham, James, Lyons, Amanda, Barnes, Kay B., Richards, Mark I., Salisbury, Anne-Marie, Craighead, Mark, Harding, Sarah V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10326817/ https://www.ncbi.nlm.nih.gov/pubmed/37370302 http://dx.doi.org/10.3390/antibiotics12060983 |
Ejemplares similares
-
CpG oligodeoxyribonucleotides protect mice from Burkholderia pseudomallei but not Francisella tularensis Schu S4 aerosols
por: Rozak, David A, et al.
Publicado: (2010) -
Nasal Acai Polysaccharides Potentiate Innate Immunity to Protect against Pulmonary Francisella tularensis and Burkholderia pseudomallei Infections
por: Skyberg, Jerod A., et al.
Publicado: (2012) -
Differential MicroRNA Analyses of Burkholderia pseudomallei- and Francisella tularensis-Exposed hPBMCs Reveal Potential Biomarkers
por: Cer, Regina Z., et al.
Publicado: (2017) -
Shotgun Immunoproteomic Approach for the Discovery of Linear B-Cell Epitopes in Biothreat Agents Francisella tularensis and Burkholderia pseudomallei
por: D’haeseleer, Patrik, et al.
Publicado: (2021) -
The Fluoroquinolone Finafloxacin Protects BALB/c Mice Against an Intranasal Infection With Francisella tularensis Strain SchuS4
por: Barnes, Kay B., et al.
Publicado: (2019)